Gene · 6624
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fascin Inhibitor NP-G2-044 Decreases Cell Metastasis while Increases Overall Survival of Mice-bearing Lung Cancers. | Curr Mol Med | 2025 | 39313904 | PubTator, text mining | PubMed |
| Cytidine deaminase enhances liver cancer invasion by modulating epithelial-mesenchymal transition via NFκB signaling. | Biomed J | 2025 | 39305991 | PubTator, text mining | PubMed |
| Ferroptosis-targeting drugs in breast cancer. | J Drug Target | 2025 | 39225187 | PubTator, text mining | PubMed |
| Comparative evaluation of Fascin-1 with clinicopathological parameters and recurrence in oral squamous cell carcinoma. | J Oral Maxillofac Pathol | 2024 | 39949678 | PubTator, text mining | PubMed |
| Inhibition of lysine-specific histone demethylase 1A suppresses adenomyosis through reduction in ectopic endometrial stromal cell proliferation, migration, and invasion. | Cytojournal | 2024 | 39737119 | PubTator, text mining | PubMed |
| Exploring the Allosteric Response of Fascin to Its Inhibitor. | J Phys Chem B | 2024 | 39621550 | PubTator, text mining | PubMed |
| FSCN1 is a Potential Therapeutic Target for Atherosclerosis Revealed by Single-Cell and Bulk RNA Sequencing. | J Inflamm Res | 2024 | 39618922 | PubTator, text mining | PubMed |
| Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors. | Nat Cardiovasc Res | 2024 | 39613875 | PubTator, text mining | PubMed |
| Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysis. | Heliyon | 2024 | 39309859 | PubTator, text mining | PubMed |
| Dock4 contributes to neuropathic pain by regulating spinal synaptic plasticity in mice. | Front Mol Neurosci | 2024 | 39282658 | PubTator, text mining | PubMed |
| Corrigendum to "Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway" [Biomed. Pharmacother. 175 (2024) 116785]. | Biomed Pharmacother | 2024 | 39256102 | PubTator, text mining | PubMed |
| miR-31-mediated local translation at the mitotic spindle is important for early development. | Development | 2024 | 39250531 | PubTator, text mining | PubMed |
| Targeting Fascin1 maintains chondrocytes phenotype and attenuates osteoarthritis development. | Bone Res | 2024 | 39231936 | PubTator, text mining | PubMed |
| A unified purification method for actin-binding proteins using a TEV-cleavable His-Strep-tag. | MethodsX | 2024 | 39224451 | PubTator, text mining | PubMed |
| Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer. | Cell Death Dis | 2024 | 39075049 | PubTator, text mining | PubMed |
| Histopathologic Features and Differential Diagnosis in Challenging Cases of Nodular Lymphocyte Predominant B-cell Lymphoma/Nodular Lymphocyte Predominant Hodgkin Lymphoma. | J Clin Transl Pathol | 2024 | 39070246 | PubTator, text mining | PubMed |
| Comparative Analysis of Breast Cancer Metabolomes Highlights Fascin's Central Role in Regulating Key Pathways Related to Disease Progression. | Int J Mol Sci | 2024 | 39063133 | PubTator, text mining | PubMed |
| Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans. | Biomedicines | 2024 | 39062096 | PubTator, text mining | PubMed |
| Role of actin-binding proteins in prostate cancer. | Front Cell Dev Biol | 2024 | 39055653 | PubTator, text mining | PubMed |
| Relationships between systemic sclerosis and atherosclerosis: screening for mitochondria-related biomarkers. | Front Genet | 2024 | 39050259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6624/papers?page=6